Remarkably, we have shown that TRIM8 is able to increase the cellular responses to UV, Nutlin-3, and cisplatin in different tumor cells, thereby playing a critical role in the outcome of DNA damaging agents treatment. Here, TRIM8 is linked to neoplasm.